Advertisement
YOU ARE HERE: LAT HomeCollections

BRIEFLY

Sterling Drug formed a joint venture in Japan.

October 29, 1985

The New York-based pharmaceutical concern and Tokyo-based Yamanouchi Pharmaceutical Co. have agreed to establish a joint-venture company to market a line of prescription drugs in Japan, the world's second-largest pharmaceuticals market after the United States. Sterling is a worldwide drug manufacturer and marketer with annual sales approaching $2 billion.

Advertisement
Los Angeles Times Articles
|
|
|